![[Bio USA] SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts](/_next/image?url=https%3A%2F%2Fwimg.heraldcorp.com%2Fnews%2Fcms%2F2025%2F06%2F22%2Fnews-p.v1.20250622.6f347ba79b0f48699e57a8849a11dca7_T1.jpg&w=3840&q=100)
[Bio USA] SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts
Korea Herald correspondent
BOSTON — SK Biopharmaceuticals CEO Lee Dong-hoon underscored the company's preparedness for potential US tariff changes and emphasized the critical role of open innovation in shaping the future of global pharmaceuticals.
'We've weathered volatility in our share price over the past year, but the impact of potential price cuts has been minimal,' Lee said Thursday during a press conference on the sidelines of the 2025 Bio USA. 'Our direct-to-market sales model remains fundamentally solid.'
He recalled a particularly tense moment earlier this year when shifting US tariff policies posed logistical challenges. In April, the company rushed to transport finished products from Canada into the US before a new tariff deadline.
'When the final truck finally cleared customs, everyone burst into applause,' he recounted.
To prevent such risks from recurring, the company now assembles finished products in Canada and ensures shipments cross the border ahead of any policy changes. Looking ahead, SK Biopharmaceuticals is evaluating Puerto Rico as a potential US-based manufacturing site, leveraging its status as a US territory and pharmaceutical hub. 'Canada is cost-effective for now, but we're preparing for every scenario,' Lee said, noting the company's tariff risk is now 'close to zero' for the year.
Lee also expressed confidence in the company's long-term growth. 'We've already announced our goal to hit 1 trillion won ($728 million) in sales by 2029, and we're on track,' he said, citing consistent profitability since last year.
A cornerstone of SK Biopharmaceuticals' strategy is open innovation. Instead of relying solely on internal research and development, the company is partnering with universities, biotech firms and research institutions. 'Major global pharmaceutical firms are moving away from in-house basic research, and so are we. When you can collaborate and generate results at a fraction of the cost, your possibilities expand," he explained.
The CEO emphasized the importance of tapping into underutilized technologies at US universities and biotech startups to diversify the company's pipeline, moving beyond its core focus on epilepsy into areas like oncology.
Artificial intelligence is another major focus area.
Lee highlighted the company's work on EEG-based seizure prediction models in collaboration with European and South American partners, along with AI algorithm development trials currently underway in Korea. 'AI is no longer optional. It's essential in every part of the business,' he said.
One standout partnership is with PhnyX Lab, whose AI-driven automation of clinical documentation significantly reduced paperwork. 'Even our US team, which was initially skeptical, was blown away,' Lee said, calling the shift 'Copernican' in scale for how it will reduce time and cost.
The CEO also outlined plans to build a global digital platform for epilepsy patients — a space where patients and physicians can share experiences and insights. 'It's not about selling drugs,' he clarified. 'It's about collecting data to inform AI-powered marketing, drug development and clinical trial design.'
The company is looking three to five years ahead, aiming to build an ecosystem where shared data drives innovation across functions.
In the US, SK Biopharmaceuticals is intensifying its engagement with health care providers. Lee has personally met with dozens of physicians this year, aiming for 100 meetings, to gather insights that will shape lifecycle strategies such as patent extensions, expanded indications and new formulations like IV delivery.
Meanwhile, SK Biopharmaceuticals has invested in targeted TV and YouTube campaigns for its flagship epilepsy drug, Xcopri (cenobamate). Its 'Road to Reduction' campaign drew 9.37 million views in just one month, signaling the brand's growing visibility and leadership in the epilepsy treatment market.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
Lee Jae Myung picks 6 more ministers, senior aides for civil affairs, social cohesion
President Lee Jae Myung on Sunday nominated six ministers, including Koo Yun-cheol, a former vice finance minister, to head the Finance Ministry, and former head of the disease control agency Jeong Eun-kyeong as health minister. The list also included Rep. Jung Sung-ho for justice minister and Rep. Yun Ho-jung for interior minister. Both lawmakers are serving their fifth terms in the National Assembly. Doosan Enerbility CEO Kim Jung-kwan was nominated as industry minister, while Lee Jin-sook, former president of Chungnam National University, was tapped for education minister. President Lee also appointed former prosecutor Bong Wook as senior civil affairs secretary, Jeon Seong-hwan as senior secretary for public engagement and social cohesion, and Kim Kyoung-soo, the former governor of South Gyeongsang Province as the head of the Presidential Committee for Decentralization and Balanced Development. Koo Yoon-cheol, a visiting professor of economics at Seoul National University, was nominated as minister of finance, in a rare recruitment from academia in Lee's Cabinet. The five-time Rep. Jung Sung-ho is one of Lee's closest allies in the Democratic Party. Jung as minister of justice is expected to carry out the Lee administration's key policy of overhauling the country's criminal justice system, centering on prosecution reform. Rep. Yun Ho-jung, a five-time Democratic Party lawmaker who was a top official in Lee's campaign team, was named minister of interior and safety. Jeong Eun-kyeong, who steered Korea's response to COVID-19 as the chief of the main disease control agency, was tapped as minister of health and welfare. Jeong retired from public office and worked as an infectious disease researcher at the Seoul National University Hospital before joining Lee's presidential campaign in April. Kim Jung-kwan, currently the president of Doosan Enerbility who served as an official at the Finance Ministry until 2018, was chosen as minister of trade, industry and energy. Kim Kyoung-soo, the former governor of South Gyeongsang Province, ran in the Democratic Party primary for presidential candidate against Lee. Kim immediately endorsed Lee after losing the primary. Kim would handle the president's policies for non-Seoul metropolitan areas, at a newly launched office named the Presidential Committee for Decentralization and Balanced Development. Lee has decided to keep another one of Yoon's ministers, by having the current Minister of Food and Drug Safety Oh Yu-Kyoung remain in office. Lee also kept Minister of Agriculture Song Mi-ryung, who was appointed by Yoon.
![[KH Interview] Korea central to BAT's smokeless pivot: COO](/_next/image?url=https%3A%2F%2Fwimg.heraldcorp.com%2Fnews%2Fcms%2F2025%2F06%2F29%2Fnews-p.v1.20250629.f0d5b07b54594595887ee1dfff0d2fa1_T1.jpg&w=3840&q=100)
Korea Herald
4 hours ago
- Korea Herald
[KH Interview] Korea central to BAT's smokeless pivot: COO
London-based tobacco giant targets 50% of sales from non-combustibles by 2035 British American Tobacco, one of the world's largest tobacco firms, is reinforcing its commitment to South Korea as a strategic hub for its smokeless transformation, positioning the country as both a key innovation testbed and a competitive frontline for next-generation nicotine alternatives, according to the group's top executive. BAT Group Chief Operating Officer Johan Vandermeulen said Korea's value to the London-based group extends far beyond immediate sales, speaking in an exclusive interview with The Korea Herald at the headquarters of the group's Korean unit, BAT Rothmans, in Seoul on June 20. 'Korea offers a unique blend of sophisticated consumers, cutting-edge technology and a dynamic regulatory environment that makes it an ideal testing ground for our next-generation products,' said Vandermeulen, a 30-year BAT veteran who assumed the role of global COO in 2023. He visited Korea as part of an Asia tour that also included Japan and China. Korea was the second market globally to launch BAT's tobacco heating product Glo in 2017, and is currently the second-largest heated products market globally — two signs that reflect BAT's confidence in Korea as a proving ground for innovation, he said. Since then, the Korean heated tobacco market has become one of the most competitive in the world, with nearly every major global player vying for market share. BAT is aiming to stay ahead by focusing on product innovation, localization strategies and technology enhancements tailored to Korean consumers, who Vandermeulen described as 'distinct and trend-sensitive.' 'BAT Rothmans here possesses exceptional capabilities, and our manufacturing facility in Sacheon (in South Gyeongsang Province) is regarded as one of the best within the entire BAT Group,' he added. 'Innovation, technology and talent — these are the core strengths of the Korean market, and why BAT is so focused on it.' The company's Glo Hyper series was the first device in its lineup to feature a display screen and boost button, both aimed at improving user experience. BAT developed the heating sticks specifically for the Korean consumer palate. BAT has also rolled out its vapor brand, Vuse, in Korea, emphasizing quality, product stewardship and responsible marketing. The devices come in various formats — slim and box types — and exclude flavors and features that could appeal to minors. 'We ensure that our vapor products are first stewarded at an ingredient level. Ingredients to be included in e-liquids must be, at minimum, food grade, with nicotine being pharmaceutical grade. We believe similar standards should be formally introduced and required for vaping products across the industry,' he said. Alongside Glo and Vuse, BAT is expanding globally into nicotine pouches — a category that does not involve inhalation and is now its fastest-growing segment, already launched in over 40 markets. While not yet available in Korea, the company sees opportunity as consumer preferences continue to evolve. At the heart of BAT's strategy is its mission of "A Better Tomorrow," which aims to build "A Smokeless World" by offering science-backed, non-combustible alternatives. The company aims to increase the revenue share from these products to 50 percent of its total by 2035, up from the current 17.5 percent, and to grow its adult user base to 50 million by 2030, from over 29 million today. This transformation aligns with BAT's Tobacco Harm Reduction philosophy. 'We aim to offer alternatives with reduced risk profile to cigarettes to adult smokers who would otherwise continue to smoke, thereby making a positive contribution to reduce the public health burden associated with cigarette smoking,' Vandermeulen said. On regulation, BAT supports clear, fair and consistent policies across the industry. 'We believe regulation should be clear, consistent and fairly applied. Provided these conditions are met, we view regulatory changes positively.' Still, Vandermeulen expressed concern over the rise of illicit vaping products, warning they undermine public trust and legitimate market efforts. 'This is ultimately about corporate responsibility,' he said. 'Proper regulation and enforcement are essential to protect consumers and ensure fair competition.' With nearly one billion smokers still using traditional cigarettes worldwide and only about 115 million having switched to smokeless alternatives, Vandermeulen said the stakes are high. 'We believe vaping has a vital role in encouraging adult smokers, who would otherwise continue smoking, to switch completely to smokeless alternatives. But the category can only thrive if market order is preserved.'
Korea Herald
5 hours ago
- Korea Herald
HD Hyundai Electric, Bulk team up for data center
HD Hyundai Electric, a Korean power grid solution provider, announced Sunday that it has formed a partnership with Norwegian data infrastructure company Bulk Infrastructure Group to strengthen its presence in the European data center market. The agreement, recently signed by both companies, outlines collaboration in supplying power equipment for data centers, including power transformers and high-voltage circuit breakers. The signing was attended by Yang Jae-cheol, executive vice president of HD Hyundai Electric's high-voltage power equipment division, and Torbjorn Moe, chief business development officer at Bulk Infrastructure Group. 'The partnership offers HD Hyundai Electric a bridgehead into Europe's data center sector, supporting its efforts to increase market share in the region,' a company official said. 'Through our R&D centers in Switzerland and Hungary, we plan to enhance our technological capabilities by developing eco-friendly power solutions tailored to the European market, while accelerating expansion efforts.' Under the agreement, HD Hyundai Electric will be given priority consideration when supplying equipment for Bulk Infrastructure's future data center projects. Bulk currently operates five data centers across Norway and Denmark and is pursuing further expansion amid rising demand across Europe. According to global consulting firm McKinsey & Co., electricity consumption by European data centers is expected to nearly triple by 2030 — from around 62 terawatt-hours in 2024 to over 150 terawatt-hours — driven largely by the growing reliance on artificial intelligence worldwide. Their share of total electricity consumption in the region is also projected to rise from 2 percent to 5 percent, positioning Europe as the third-largest data center power market after China and the US. The new partnership builds on HD Hyundai Electric's earlier delivery of a super high-voltage transformer to a large-scale data center operated by Bulk Infrastructure in Vennesla, Norway. Europe has emerged as a key market for HD Hyundai Electric, with the company expanding its presence across the region. In May, it entered the Scottish market by supplying four high-voltage transformers for a new substation project.
